Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy

Immune checkpoint inhibitors used to treat malignancies may lead to various immune-related adverse events (irAEs) including conditions such as myositis and myasthenia gravis (MG). Here, we describe 2 cases of myositis treated effectively with therapeutic plasma exchange (PLEX). A 64-year-old man wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Katyal, Nakul, Katsumoto, Tamiko R., Ramachandran, Kavitha J., Yunce, Muharrem, Muppidi, Srikanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Clinical Neuromuscular Disease 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645099/
https://www.ncbi.nlm.nih.gov/pubmed/37962196
http://dx.doi.org/10.1097/CND.0000000000000457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645099/
https://www.ncbi.nlm.nih.gov/pubmed/37962196
http://dx.doi.org/10.1097/CND.0000000000000457

Ejemplares similares